Both thymomas and TC overexpress vascular endothelial growth factor (VEGF)-A and VEGFR-1 and -2, although there is little information on the effectiveness of angiogenesis inhibitors in thymic malignancies [79,80]. This evidence concerns the gene FLT1 and thymoma.